PARKINSON DISEASE PSYCHOSIS
Clinical trials for PARKINSON DISEASE PSYCHOSIS explained in plain language.
Never miss a new study
Get alerted when new PARKINSON DISEASE PSYCHOSIS trials appear
Sign up with your email to follow new studies for PARKINSON DISEASE PSYCHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a Low-Dose seizure drug quiet Parkinson's psychosis?
Symptom relief Recruiting nowThis study tests whether AGB101, a low-dose seizure medication, can reduce hallucinations and delusions in people with Parkinson's disease. About 30 adults aged 40-85 will take the drug and a placebo at different times, with brain scans and questionnaires to track changes. The go…
Matched conditions: PARKINSON DISEASE PSYCHOSIS
Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Brain scan tracer could reveal hidden signs of psychosis in Parkinson's
Knowledge-focused Recruiting nowThis study uses a special PET scan tracer, [18F]MH.MZ, to measure serotonin 2A receptors in the brains of people with neurodegenerative diseases like Parkinson's. Researchers want to see if these receptors differ between patients with psychosis and healthy people of the same age.…
Matched conditions: PARKINSON DISEASE PSYCHOSIS
Phase: PHASE4 • Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Aug 09, 2026 00:00 UTC